Lesion-directed Screening May be as Effective as Total-Body Examination

Share this content:
Lesion-directed screening is comparably effective and may be less time consuming.
Lesion-directed screening is comparably effective and may be less time consuming.

Although total-body examination in screening for skin cancer may be able to detect a higher absolute number of cancers, lesion-directed screening is comparably effective and may be less time consuming, according to a recent study published online ahead of print in JAMA Dermatology.

Isabelle Hoorens, MD, of the University Hospital Ghent in Belgium looked at 1,982 patients as part of a population-based cross-sectional screening by a team of six dermatologists in two sociodemographically similar regions who were screened with either total-body examination or lesion-directed screening. They focused on participation rate, detection rate, anxiety and cost.

The researchers found that the skin cancer detection rate per 100 participants did not differ significantly between the two groups, with 2.3% in the total-body examination group and 3.2% in the lesion-directed screening group. Operational effectiveness was found to be 0.4% in the total-body group compared to 0.1% in the lesion-directed group.

In addition, lesion-directed screening was 5.6 times less time consuming than total-body examination, although patients in the former group had a higher baseline anxiety.

“When performed by dermatologists, lesion-directed screening is an acceptable alternative screening method in health care systems with limited budgets or long waiting lists,” the authors concluded.


1. Hoorens I, Vossaert K, Pil L, et al. Total-Body Examination vs Lesion-Directed Skin Cancer Screening [published online ahead of print October 14, 2015]. JAMA Dermatology. doi:10.1001/jamadermatol.2015.2680.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs